v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Common Stock
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Distributions in Excess of Net Income
Non-Controlling Interests in Consolidated Joint Ventures
Total
Beginning Balance at Dec. 31, 2024 $ 20,698 $ 335,539 $ 208 $ (49,020) $ 1,150 $ 308,575
Increase (Decrease) in Stockholders' Equity            
Cash distributions - common stock       (9,804)   (9,804)
Shares issued through dividend reinvestment plan 7 180       187
Restricted stock vesting 139 (139)        
Compensation expense - restricted stock and RSUs   1,346       1,346
Distributions to non-controlling interests         (63) (63)
Net income       4,155 14 4,169
Other comprehensive loss     (78)     (78)
Ending Balance at Mar. 31, 2025 20,844 336,926 130 (54,669) 1,101 304,332
Beginning Balance at Dec. 31, 2024 20,698 335,539 208 (49,020) 1,150 308,575
Increase (Decrease) in Stockholders' Equity            
Net income           13,587
Ending Balance at Jun. 30, 2025 20,854 338,401 72 (55,939) 376 303,764
Beginning Balance at Mar. 31, 2025 20,844 336,926 130 (54,669) 1,101 304,332
Increase (Decrease) in Stockholders' Equity            
Cash distributions - common stock       (9,701)   (9,701)
Shares issued through dividend reinvestment plan 8 181       189
Restricted stock vesting 2 (2)        
Compensation expense - restricted stock and RSUs   1,296       1,296
Distributions to non-controlling interests         (1,712) (1,712)
Net income       8,431 987 9,418
Other comprehensive loss     (58)     (58)
Ending Balance at Jun. 30, 2025 20,854 338,401 72 (55,939) 376 303,764
Beginning Balance at Dec. 31, 2025 20,916 341,389 16 (62,718) 194 299,797
Increase (Decrease) in Stockholders' Equity            
Cash distributions - common stock       (9,872)   (9,872)
Shares issued through dividend reinvestment plan 7 135       142
Restricted stock vesting 146 (146)        
Compensation expense - restricted stock and RSUs   1,267       1,267
Distributions to non-controlling interests         (8) (8)
Net income       6,237 3 6,240
Other comprehensive loss     (7)     (7)
Ending Balance at Mar. 31, 2026 21,069 342,645 9 (66,353) 189 297,559
Beginning Balance at Dec. 31, 2025 20,916 341,389 16 (62,718) 194 299,797
Increase (Decrease) in Stockholders' Equity            
Net income           21,905
Ending Balance at Jun. 30, 2026 21,075 344,021   (60,684) 187 304,599
Beginning Balance at Mar. 31, 2026 21,069 342,645 9 (66,353) 189 297,559
Increase (Decrease) in Stockholders' Equity            
Cash distributions - common stock       (9,989)   (9,989)
Shares issued through dividend reinvestment plan 6 129       135
Compensation expense - restricted stock and RSUs   1,247       1,247
Distributions to non-controlling interests         (9) (9)
Net income       15,658 7 15,665
Other comprehensive loss     $ (9)     (9)
Ending Balance at Jun. 30, 2026 $ 21,075 $ 344,021   $ (60,684) $ 187 $ 304,599